The overlapping morphological and genetic characteristics among entities in the heterogeneous group of LBCL necessitate the clinical distinction of HGBCL, not otherwise specified (NOS) from the DLBCL/HGBCL group with MYC and BCL2 rearrangements. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.